Literature DB >> 29863292

Recent Advances in the Development of Indazole-based Anticancer Agents.

Jinyun Dong1, Qijing Zhang1, Zengtao Wang1, Guang Huang1, Shaoshun Li1.   

Abstract

Cancer is one of the leading causes of human mortality globally; therefore, intensive efforts have been made to seek new active drugs with improved anticancer efficacy. Indazole-containing derivatives are endowed with a broad range of biological properties, including anti-inflammatory, antimicrobial, anti-HIV, antihypertensive, and anticancer activities. In recent years, the development of anticancer drugs has given rise to a wide range of indazole derivatives, some of which exhibit outstanding activity against various tumor types. The aim of this review is to outline recent developments concerning the anticancer activity of indazole derivatives, as well as to summarize the design strategies and structure-activity relationships of these compounds.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  1H-indazoles; 2H-indazoles; anticancer agents; kinase inhibitors

Mesh:

Substances:

Year:  2018        PMID: 29863292     DOI: 10.1002/cmdc.201800253

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  18 in total

1.  Development of benzochalcone derivatives as selective CYP1B1 inhibitors and anticancer agents.

Authors:  Jinyun Dong; Guang Huang; Qijing Zhang; Zengtao Wang; Jiahua Cui; Yan Wu; Qingqing Meng; Shaoshun Li
Journal:  Medchemcomm       Date:  2019-07-02       Impact factor: 3.597

2.  Subcellular distribution of ezrin/radixin/moesin and their roles in the cell surface localization and transport function of P-glycoprotein in human colon adenocarcinoma LS180 cells.

Authors:  Takuro Kobori; Mayuka Tameishi; Chihiro Tanaka; Yoko Urashima; Tokio Obata
Journal:  PLoS One       Date:  2021-05-11       Impact factor: 3.240

3.  Synthesis of 1H-Indazoles via Silver(I)-Mediated Intramolecular Oxidative C-H Bond Amination.

Authors:  Areum Park; Kyu-Sung Jeong; Hyuk Lee; Hyunwoo Kim
Journal:  ACS Omega       Date:  2021-02-23

4.  Rapid and halide compatible synthesis of 2-N-substituted indazolone derivatives via photochemical cyclization in aqueous media.

Authors:  Hui-Jun Nie; An-Di Guo; Hai-Xia Lin; Xiao-Hua Chen
Journal:  RSC Adv       Date:  2019-04-30       Impact factor: 4.036

5.  Theoretical Investigations on Interactions of Arylsulphonyl Indazole Derivatives as Potential Ligands of VEGFR2 Kinase.

Authors:  Kornelia Czaja; Jacek Kujawski; Paweł Śliwa; Rafał Kurczab; Radosław Kujawski; Anna Stodolna; Agnieszka Myślińska; Marek K Bernard
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

6.  Selected arylsulphonyl pyrazole derivatives as potential Chk1 kinase ligands-computational investigations.

Authors:  Kornelia Czaja; Jacek Kujawski; Karol Kamel; Marek K Bernard
Journal:  J Mol Model       Date:  2020-05-18       Impact factor: 1.810

Review 7.  Recent Advances in Indazole-Containing Derivatives: Synthesis and Biological Perspectives.

Authors:  Shu-Guang Zhang; Chao-Gen Liang; Wei-Hua Zhang
Journal:  Molecules       Date:  2018-10-26       Impact factor: 4.411

8.  A Suitable Functionalization of Nitroindazoles with Triazolyl and Pyrazolyl Moieties via Cycloaddition Reactions.

Authors:  Mohammed Eddahmi; Nuno M M Moura; Latifa Bouissane; Ouafa Amiri; M Amparo F Faustino; José A S Cavaleiro; Ricardo F Mendes; Filipe A A Paz; Maria G P M S Neves; El Mostapha Rakib
Journal:  Molecules       Date:  2019-12-28       Impact factor: 4.411

9.  Identification of Novel PI3Kδ Selective Inhibitors by SVM-Based Multistage Virtual Screening and Molecular Dynamics Simulations.

Authors:  Jing-Wei Liang; Shan Wang; Ming-Yang Wang; Shi-Long Li; Wan-Qiu Li; Fan-Hao Meng
Journal:  Int J Mol Sci       Date:  2019-11-28       Impact factor: 5.923

10.  Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents.

Authors:  Lucas N Solano; Grady L Nelson; Conor T Ronayne; Shirisha Jonnalagadda; Sravan K Jonnalagadda; Kaija Kottke; Robert Chitren; Joseph L Johnson; Manoj K Pandey; Subash C Jonnalagadda; Venkatram R Mereddy
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.